Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,751–4,775 of 7,816 matching trials · page 191 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Study of the Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants NCT04394845 [18F]GTP1 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 6 | Genentech, Inc. INDUSTRY |
2021-11-03 |
|
Latest Imaging SPECT System Evaluation Phase 1 NCT04704349 Scintigraphy Runs in: France · 1 site |
NA other |
COMPLETED | 68 | Centre Hospitalier Régional d'Orléans OTHER |
2021-11-03 |
|
Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients NCT00013585 Selegiline hydrochloride Runs in: United States · 15 sites |
PHASE2 other |
COMPLETED | 127 | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
2021-11-01 |
|
Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life NCT01796314 Therapeutic Educational Program Runs in: France · 1 site |
NA other |
COMPLETED | 170 | University Hospital, Toulouse OTHER |
2021-11-01 |
|
Spanish Translation and Cultural Adaptation of the Memory Support System NCT03933085 Memory Support System (MSS) Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | Mayo Clinic OTHER |
2021-11-01 |
|
Umuryango Ukomera Uri Hamwe - Families Are Strong Together NCT04061954 Comprehensive family intervention including individual sessions of FORNET Runs in: Burundi · 1 site |
NA other |
COMPLETED | 150 | University of Konstanz OTHER |
2021-11-01 |
|
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers NCT04567745 Retinal fundus photography Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 80 | Mayo Clinic OTHER |
2021-11-01 |
|
The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease NCT05102045 Repetitive Transcranial Magnetic Stimulation; Aerobic Exercise; Ace... Runs in: Turkey (Türkiye) · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 27 | Istanbul Medipol University Hospital OTHER |
2021-11-01 |
|
An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts NCT00000709 Zidovudine Runs in: United States · 12 sites |
PHASE3 other |
COMPLETED | 50 | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
2021-10-29 |
|
Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database NCT04613089 Natural History Runs in: Germany · 1 site |
NA other |
RECRUITING | 500 | Universitätsklinikum Hamburg-Eppendorf OTHER |
2021-10-29 |
|
A Study of CST-2032 in Subjects With Cognitive Impairment NCT05033912 CST-2032, matching placebo for CST-2032, CST-107 |
PHASE1 other |
WITHDRAWN | 0 | CuraSen Therapeutics, Inc. INDUSTRY |
2021-10-28 |
|
Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease NCT03402659 neflamapimod; placebo Runs in: Czechia; Denmark; Netherlands; United Kingdom; United States · 38 sites |
PHASE2 other |
COMPLETED | 161 | EIP Pharma Inc INDUSTRY |
2021-10-27 |
|
Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD) NCT03288363 tDCS Runs in: France · 1 site |
NA other |
UNKNOWN | 80 | Benjamin CALVET OTHER |
2021-10-22 |
|
A Study of ACI-24 in Adults With Down Syndrome NCT04373616 ACI-24; Placebo |
PHASE2 other |
WITHDRAWN | 0 | AC Immune SA INDUSTRY |
2021-10-22 |
|
A Comparative Study of Brain Structure and Amyloid Load in MCI Patients NCT03773185 Runs in: Hong Kong · 1 site |
NA other |
WITHDRAWN | 0 | Chinese University of Hong Kong OTHER |
2021-10-21 |
|
Combined Cognitive and Vocational Interventions After Mild-to-moderate TBI: a Randomized Controlled Trial NCT03092713 Combined cognitive (Compensatory Cognitive Training - CCT) and voca... Runs in: Norway · 1 site |
NA other |
COMPLETED | 121 | Oslo University Hospital OTHER |
2021-10-19 |
|
Individualized Cognitive Training in HIV NCT03122288 Individualized Cognitive Training; No-Contact Control Runs in: United States · 1 site |
NA other |
COMPLETED | 109 | University of Alabama at Birmingham OTHER |
2021-10-19 |
|
Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study NCT03554226 NeuroPsychiatric Inventory Clinician (NPI-C) Runs in: France · 1 site |
NA other |
COMPLETED | 270 | University Hospital, Toulouse OTHER |
2021-10-14 |
|
Health and Aging Brain Study: Health Disparities Tau Positron Emission Tomography (PET) Scan Study NCT05076331 PI-2620 tracer for Tau PET scan Runs in: United States · 1 site |
NA other |
UNKNOWN | 3,000 | University of North Texas Health Science Center OTHER |
2021-10-13 |
|
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease NCT01388478 R-pramipexole Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 20 | Virginia Commonwealth University OTHER |
2021-10-12 |
|
A Four Month Home Based tDCS Study on Patients With Alzheimer's Disease. NCT04759092 transcranial direct current stimulation (tDCS) Runs in: Norway · 1 site |
NA other |
COMPLETED | 8 | University Hospital of North Norway OTHER |
2021-10-11 |
|
Magnetic Brain Stimulation in the Treatment of Mild Cognitive Impairment NCT02420522 Repetitive Transcranial Magnetic Stimulation; Sham Transcranial Mag... Runs in: Canada · 1 site |
NA other |
SUSPENDED | 64 | University of Manitoba OTHER |
2021-10-08 |
|
Vietnamese Caregiver Intervention Study NCT03218982 Enhanced psycho-education about dementia and caregiving Runs in: United States · 1 site |
NA other |
COMPLETED | 11 | University of California, Davis OTHER |
2021-10-08 |
|
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting NCT03448445 Usual care setting Runs in: South Korea · 16 sites |
NA other |
COMPLETED | 201 | Eisai Korea Inc. INDUSTRY |
2021-10-06 |
|
Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study NCT03134963 Transcranial doppler ultrasonography; Blood pressure monitoring; He... Runs in: United Kingdom · 2 sites |
NA other |
COMPLETED | 42 | University of Leicester OTHER |
2021-10-05 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial